Use Of Complementary and Alternative Medicine in Children With Cancer: Effect on Survival

REFERENCES

• Kelly KM. Bringing evidence to complementary and alternative medicine in children with cancer: focus on nutrition-related therapies. Pediatr Blood Cancer. 2008;50:490–493.
   PubMed Web of Science ®Google Scholar
• National Center for Complementary and Alternative Medicine. What Is Complementary and Alternative Medicine (2002). Available at: http://nccam.nih.gov/health/whatiscam/D156.pdf. Accessed November 24, 2006.
   Google Scholar
• Kelly KM. Complementary and alternative medicines for use in supportive care in pediatric cancer. Support Care Cancer. 2007;15:457–460.
   PubMed Web of Science ®Google Scholar
• Kelly KM. Complementary and alternative medical therapies for children with cancer. Eur J Cancer. 2004;40:2041–2046.
   PubMed Web of Science ®Google Scholar
• Gözüm S, Arikan D, Buyukavcı M. Complementary and alternative medicine use in pediatric oncology patients in eastern Turkey. Cancer Nurs. 2007;30:38–44.
   PubMed Web of Science ®Google Scholar
• Karadeniz C, Pinarli FG, Oguz A, Complementary/alternative medicine use in a pediatric oncology unit in Turkey. Pediatr Blood Cancer. 2007;48:540–543.
   Google Scholar
• Samur M, Bozcuk HS, Kara A, Factors associated with utilization of nonproven cancer therapies in Turkey: a study of 135 patients from a single center. Support Care Cancer. 2001;9:452–458.
   Google Scholar
• Ceylan S, Hamzaoglu O, Komurcu S, Survey of the use of complementary and alternative medicine among Turkish cancer patients. Complement Ther Med. 2002;10:94–99.
   Google Scholar
• Risberg T, Vickers A, Bremnes RM, Does use of alternative medicine predict survival from cancer? Eur J Cancer. 2003;39:372–377.
   Google Scholar
• Richardson MA, Russell NC, Sanders T, Assessment of outcomes at alternative medicine cancer clinics: a feasibility study. J Altern Complement Med. 2001;7:19–32.
   PubMed Web of Science ®Google Scholar
• Sencer SF, Kelly KM. Complementary and alternative therapies in pediatric oncology. Pediatr Clin North Am. 2007;54:1043–1060.
   PubMed Web of Science ®Google Scholar
• McCurdy EA, Spangler JG, Wofford MM, Religiosity is associated with the use of complementary medical therapies by pediatric oncology patients. J Pediatr Hematol Oncol. 2003;25:125–129.
   Google Scholar
• Faw C, Ballentine R, Ballentine L, Unproved cancer remedies. A survey of use in pediatric outpatients. JAMA. 1977;238:1536–1538.
   Google Scholar
• Nathanson I, Sandler E, Ramirez-Garnica G, Factors influencing complementary and alternative medicine use in a multisite pediatric oncology practice. J Pediatr Hematol Oncol. 2007;29:705–708.
   PubMed Web of Science ®Google Scholar
• Fernandez CV, Stutzer CA, MacWilliam L, Alternative and complementary therapy use in pediatric oncology patients in British Columbia: prevalence and reasons for use and nonuse. J Clin Oncol. 1998;16:1279–1286.
   PubMed Web of Science ®Google Scholar
• Martel D, Bussieres JF, Theoret Y, Use of alternative and complementary therapies in children with cancer. Pediatr Blood Cancer. 2005;44:660–668.
   PubMed Web of Science ®Google Scholar
• Gomez-Martinez R, Tlacuilo-Parra A, Garibaldi-Covarrubias R. Use of complementary and alternative medicine in children with cancer in Occidental, Mexico. Pediatr Blood Cancer. 2007;49:820–823.
   Google Scholar
• Langler A, Spix C, Gottschling S, Parents-interview on use of complementary and alternative medicine in pediatric oncology in Germany. Klin Padiatr. 2005;217:357–364.
   Google Scholar
• Molassiotis A, Cubbin D. “Thinking outside the box”: complementary and alternative therapies use in pediatric oncology patients. Eur J Oncol Nurs. 2004;8:50–60.
   Google Scholar
• Grootenhuis MA, Last BF, de Graff-Nijkerk JH, Use of alternative treatment in pediatric oncology. Cancer Nurs. 1998;21:282–288.
   PubMed Web of Science ®Google Scholar
• Yeh CH, Tsai JL, Li W, Use of alternative therapy among pediatric oncology patients in Taiwan. Pediatr Hematol Oncol. 2000;17:55–65.
   Web of Science ®Google Scholar
• Lim J, Wong M, Chan MY, Use of complementary and alternative medicine in paediatric oncology patients in Singapore. Ann Acad Med Singapore. 2006;35:753–758.
   PubMed Web of Science ®Google Scholar
• Bold J, Leis A. Unconventional therapy use among children with cancer in Saskatchewan. J Pediatr Oncol Nurs. 2001;18:16–25.
   Google Scholar
• Friedman T, Slayton WB, Allen LS, et al. Use of alternative therapies for children with cancer. Pediatrics. 1997;100(6):E1.
   Google Scholar
• Neuhouser ML, Patterson RE, Schwartz SM, Use of alternative medicine by children with cancer in Washington State. Prev Med. 2001;33:347–354.
   PubMed Web of Science ®Google Scholar
• Fletcher PC, Clarke J. The use of complementary and alternative medicine among pediatric patients. Cancer Nurs. 2004;27:93–99.
   PubMed Web of Science ®Google Scholar
• Loman DG. The use of complementary and alternative health care practices among children. J Pediatr Health Care. 2003;17:58–63.
   Google Scholar
• Sawyer MG, Gannoni AF, Toogood IR, The use of alternative therapies by children with cancer. Med J Aust. 1994;160:320–322.
   PubMed Web of Science ®Google Scholar
• Spigelblatt L, Laine-Ammara G, Pless IB, The use of alternative medicine by children. Pediatrics. 1994;94:811–814.
   PubMed Web of Science ®Google Scholar
• Malik IA, Khan NA, Khan W. Use of unconventional methods of therapy by cancer patients in Pakistan. Eur J Epidemiol. 2000;16:155–160.
   PubMed Web of Science ®Google Scholar
• Marchetti S, Mazzanti R, Beijnen JH, Concise review: clinical relevance of drug-drug and herb-drug interactions mediated by the ABC transporter ABCB1 (MDR1, P-glycoprotein). Oncologist. 2007;12:927–941.
   PubMed Web of Science ®Google Scholar
• Ernst E. Serious adverse effects of unconventional therapies for children and adolescents: a systematic review of recent evidence. Eur J Pediatr. 2003;162:72–80.
   PubMed Web of Science ®Google Scholar
• Buiatti E, Arniani S, Verdecchia A, Results from a historical survey of the survival of cancer patients given Di Bella multitherapy. Cancer. 1999;86:2143–2149.
   Google Scholar